Form S-1/A bioAffinity Technologies
Tweet
Share
E-mail
http://archive.fast-edgar.com/20220616/AK2EVQ2CZC2RUZOX222N2ZY2JB5DZZ22Z242
Filed on: June 16, 2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- bioAffinity publishes clinical framework for CyPath Lung nodule testing
- ViiV Healthcare HIV drug Cabenuva outperforms daily oral therapy in teens
- Johnson & Johnson buys Firefly Bio for $1B to expand oncology work
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
